Rabbit Recombinant Monoclonal PRA1 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
ICC/IF | WB | IHC-P | |
---|---|---|---|
Human | Not recommended | Tested | Not recommended |
Mouse | Not recommended | Predicted | Not recommended |
Rat | Not recommended | Predicted | Not recommended |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/1000 - 1/20000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Rat | Dilution info - | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Human, Mouse, Rat | Dilution info - | Notes - |
General Rab protein regulator required for vesicle formation from the Golgi complex. May control vesicle docking and fusion by mediating the action of Rab GTPases to the SNARE complexes. In addition it inhibits the removal of Rab GTPases from the membrane by GDI.
PRA1, PRAF1, RABAC1, Prenylated Rab acceptor protein 1, PRA1 family protein 1
Rabbit Recombinant Monoclonal PRA1 antibody. Suitable for WB and reacts with Human samples. Cited in 1 publication.
pH: 7.2 - 7.4
Preservative: 0.01% Sodium azide
Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9% PBS, 0.05% BSA
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
This product is a recombinant monoclonal antibody, which offers several advantages including:
For more information, read more on recombinant antibodies.
PRA1 protein also known as prenylated Rab acceptor 1 is involved in vesicular transport processes within the cell. This protein has a molecular mass of approximately 21 kDa and plays an important role in the trafficking of proteins bound for various destinations in the secretory pathway. PRA1 is widely expressed in many tissues reflecting its integral function in cellular transport mechanisms.
PRA1 interacts with Rab GTPases which suggest its role in facilitating the docking or fusion of transport vesicles with target membranes. Although it does not form a complex on its own PRA1 acts as an effector anchoring prenylated Rab proteins. This interaction is essential for maintaining the fidelity and specificity of vesicle transport events necessary for proper cellular functioning.
PRA1 participates in the regulation of the Rab GTPase cycle and is important in the endocytic and secretory pathways. It modulates the activity of proteins such as Rab1 and Rab5 that coordinate the movement of vesicles from the endoplasmic reticulum to the Golgi and from the Golgi to the plasma membrane. These pathways are fundamental for cellular logistics ensuring that proteins reach the intracellular or extracellular locations where they are needed.
PRA1 has been linked to neurodegenerative conditions like Alzheimer's disease possibly due to its involvement in vesicular transport and protein trafficking dysregulation. Alterations in PRA1 expression or function can affect proteins such as Rab proteins potentially contributing to the pathological process of such disorders. Another condition associated with PRA1 is Charcot-Marie-Tooth disease suggesting its importance in neuronal maintenance and integrity.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
ab76413 Anti-PRA1 antibody [EPR1747Y] was shown to specifically react with PRA1 in wild-type HeLa cells. Loss of signal was observed when knockout cell line Human RABAC1 (PRA1) knockout HeLa cell line ab265702 (knockout cell lysate Human RABAC1 (PRA1) knockout HeLa cell lysate ab258162) was used. Wild-type and PRA1 knockout samples were subjected to SDS-PAGE. ab76413 and Anti-alpha Tubulin antibody [DM1A] - Loading Control (Anti-alpha Tubulin antibody [DM1A] - Loading Control ab7291) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes: Western blot - Anti-PRA1 antibody [EPR1747Y] (ab76413) at 1/1000 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: RABAC1 knockout HeLa cell lysate at 20 µg
Lane 2: Western blot - Human RABAC1 (PRA1) knockout HeLa cell line (Human RABAC1 (PRA1) knockout HeLa cell line ab265702)
Lane 3: HEK293 cell lysate at 20 µg
All lanes: Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773) at 1/20000 dilution
Predicted band size: 21 kDa
Observed band size: 21 kDa
All lanes: Western blot - Anti-PRA1 antibody [EPR1747Y] (ab76413) at 1/2000 dilution
All lanes: 293 cell lysate at 10 µg
All lanes: HRP labelled goat anti-rabbit at 1/2000 dilution
Predicted band size: 21 kDa
Observed band size: 21 kDa
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com